Search
Eton Pharmaceuticals Inc
ETONAdd to Watchlist
56.460USD
+9.310+19.75%
Close 11-06 16:00（ET）
1.61BMarket Cap
LossP/E TTM
Today
+19.75%
5 Days
+8.20%
1 Month
+2.88%
6 Months
+82.01%
Year to Date
+233.89%
1 Year
+234.08%
Key Figures
58.590Open
58.590High
87.41KVolume
LossP/E TTM
25.10P/E Dynamic
--Dividend TTM
0.31%Turnover Ratio
47.150Prev. Close
51.820Low
4.84MTurnover
LossP/E Static
61.78P/B
0.00%Div Yield TTM
-1.62%ROA
66.37052wk High
0.19Volume Ratio
-3.82MNet Profit
28.58MShares
-0.0556EPS TTM
0.88Beta
-5.36%ROE
14.27052wk Low
22.15%Amplitude
70.50%Gross Margin
1.61BMarket Cap
13.15Reward/Risk
4.61%Risk Rate
Eton Pharmaceuticals Inc's Score
0.12vs previous score
Forecast8.00
Financial Health8.38
Technical4.42
Valuation Dimensions9.26
Institutional Confidence5.00
Risk Assessment4.72
Media Coverage
Coverage Level
Very Low
Very High
Positive+
Analyst Rating
Eton Pharmaceuticals Inc Technical Analysis
Technical Indicators
Buy
Summary
Buy
Moving Average
Strong buy
Eton Pharmaceuticals Inc Latest Earnings Call Transcripts
Eton Pharmaceuticals (ETON) Q3 2026 Earnings Call: Revenue Jumps 158%, Guidance Raised
Eton Pharmaceuticals’ Q3 2026 earnings call covered 158% revenue growth to $57.9 million, a 49% adjusted EBITDA margin and raised 2026 guidance.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
1.23/0.31
Revenue / Forecast
57.92M/38.86M
Eton Pharmaceuticals Inc Profile
SectorPharmaceuticals
Ticker SymbolETON
Number of employees31
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Opaleye Management Inc. | 10.45% |
| EcoR1 Capital, LLC | 7.42% |
| BlackRock Institutional Trust Company, N.A. | 5.74% |
| Nantahala Capital Management, LLC | 4.30% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 19.72% |
| Hedge Fund | 18.49% |
| Investment Advisor/Hedge Fund | 15.20% |
| Individual Investor | 4.94% |
Related Instruments
-0.79%
+1.43%
+1.07%
-0.14%
+0.38%
-0.22%
+0.03%
-0.41%
+0.02%
-0.20%
+0.85%
-1.57%
-1.04%
+0.28%
+5.27%
-0.16%
+0.16%
-0.80%
+1.46%
+3.63%Popular Instruments
51290.600
-208.500 (-0.41%)
26964.500
+329.300 (+1.24%)
7380.000
+23.100 (+0.31%)
12797.000
-1.000 (-0.01%)
58142.000
+876.000 (+1.53%)
6140.600
-37.200 (-0.60%)
89.857
-0.176 (-0.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4065.670
-33.020 (-0.81%)
FAQs
What is the current price of Eton Pharmaceuticals Inc (ETON)?
The current price of Eton Pharmaceuticals Inc (ETON) is 56.46.
What is the symbol of Eton Pharmaceuticals Inc?
The ticker symbol of Eton Pharmaceuticals Inc is ETON.
What is the 52-week high of Eton Pharmaceuticals Inc?
The 52-week high of Eton Pharmaceuticals Inc is 66.37.
What is the 52-week low of Eton Pharmaceuticals Inc?
The 52-week low of Eton Pharmaceuticals Inc is 14.27.
What is the market capitalization of Eton Pharmaceuticals Inc?
The market capitalization of Eton Pharmaceuticals Inc is 1.61B.
Is Eton Pharmaceuticals Inc (ETON) currently rated as Buy, Hold, or Sell?
According to analysts, Eton Pharmaceuticals Inc (ETON) has an overall rating of Buy, with a price target of 71.50.
What is the Earnings Per Share (EPS TTM) of Eton Pharmaceuticals Inc (ETON)?
The Earnings Per Share (EPS TTM) of Eton Pharmaceuticals Inc (ETON) is -0.06.